BBSome-related retinitis pigmentosa

🏷

Classifications

Harrison's Chapter

Mechanistic Nosology

🔗

Mappings

MONDO

MONDO:0013312 retinitis pigmentosa 55 Not Yet Curated

ARL6/BBS3 per-locus isolated-RP entity federated by this mechanistic class.

MONDO:1040065 ARL6-related ciliopathy Not Yet Curated

ARL6 allelic-series entity spanning isolated retinal disease and syndromic ciliopathy.

MONDO:0013274 retinitis pigmentosa 51 Not Yet Curated

TTC8/BBS8 per-locus isolated-RP entity federated by this mechanistic class.

MONDO:1040049 TTC8-related ciliopathy Not Yet Curated

TTC8 allelic-series entity spanning isolated retinal disease and syndromic ciliopathy.

MONDO:1040043 BBS1-related ciliopathy Not Yet Curated

BBS1 allelic-series entity spanning isolated retinopathy and Bardet-Biedl syndrome.

MONDO:1040048 BBS2-related ciliopathy Not Yet Curated

BBS2 allelic-series entity spanning isolated retinopathy and Bardet-Biedl syndrome.

MONDO:0700236 BBS9-related ciliopathy Not Yet Curated

BBS9 allelic-series entity spanning isolated retinal disease and syndromic ciliopathy.

📘

Definitions

2

Broad retinitis pigmentosa definition

An inherited retinal dystrophy with progressive photoreceptor and retinal pigment epithelium loss, usually leading to severe visual impairment over decades.

OTHER

Show evidence (1 reference)

ORPHA:791 SUPPORT Other

"Retinitis pigmentosa (RP) is an inherited retinal dystrophy leading to progressive loss of the photoreceptors and retinal pigment epithelium and resulting in blindness usually after several decades."

Defines the broad RP phenotype represented by MONDO:0019200.

BBSome-related isolated-RP scope

This entry includes only well-documented isolated or nearly isolated RP at ARL6, TTC8, BBS1, BBS2, and BBS9. Other BBS genes remain outside the lump until primary human evidence establishes a comparable presentation, and non-BBSome ciliary genes such as IFT172 and CFAP418 remain outside its mechanistic boundary.

OTHER

Show evidence (1 reference)

PMID:37031301 SUPPORT Human Clinical

"Diagnosis of BBS and non-syndromic retinitis pigmentosa (RP) were established in 28 patients from 27 pedigrees and 6 patients, respectively."

Confirms that nonsyndromic RP occurs within BBS-gene cohorts without making it universal.

👪

Inheritance

1

Autosomal recessive inheritance HP:0000007

The supported BBSome-related isolated-RP presentations result from biallelic pathogenic variants. Apparent modifier effects can alter expressivity, but the primary inheritance model remains autosomal recessive.

Autosomal recessive inheritance

Show evidence (2 references)

PMID:23143442 SUPPORT Human Clinical

"Variants in BBS1 are significantly associated with nonsyndromic autosomal recessive RP and relatively mild forms of BBS."

Directly documents autosomal recessive BBS1-associated nonsyndromic RP.

PMID:22353939 SUPPORT Human Clinical

"our study argues in favor of straightforward autosomal recessive BBS in most cases."

Supports a primary recessive rather than triallelic inheritance model.

?

Discussions and Knowledge Gaps

3

When should a retina-dominant BBS-gene presentation remain in an isolated-RP class rather than be classified as mild Bardet-Biedl syndrome?

INTERPRETATION OPEN bbsome_rp_lump_split_boundary

Attached to

definitions#BBSome-related isolated-RP scope differential_diagnoses#Bardet-Biedl syndrome

Published cohorts span apparently nonsyndromic RP, very mild extra-ocular disease, and full BBS. Age at assessment and the intensity of systemic phenotyping can change the label. This entry therefore uses a mechanism-based lump while retaining the clinical boundary as uncertain.

Show evidence (1 reference)

PMID:37031301 SUPPORT Human Clinical

"The patients exhibited clinical heterogeneity, from patients with all six primary clinical components to patients suffering from non-syndromic RP."

Demonstrates the continuum that makes the classification boundary unstable.

How consistently does residual BBSome function predict retina-restricted disease across genes and allelic combinations?

KNOWLEDGE GAP OPEN hypomorphic_allele_model_limits

Attached to

pathophysiology#Partial or retina-selective BBSome dysfunction

Tissue-specific TTC8 and ARL6 effects and partial BBS9 splicing support a residual-function model, but BBS1 expressivity also implicates cis- or trans-acting modifiers. The model should not be generalized to every missense allele without functional and longitudinal clinical data.

Show evidence (1 reference)

PMID:23143442 SUPPORT Human Clinical

"cis - or trans -acting modifiers may influence the disease phenotype."

Directly identifies modifier effects as an alternative to a simple allele-severity rule.

Will preclinical neuroprotection or BBS1 gene augmentation preserve useful vision in humans with BBSome-related retinal degeneration?

KNOWLEDGE GAP OPEN bbsome_rp_translation

Attached to

clinical_trials#NCT07269665 animal_models#Bbs1 p.Met390Arg homozygous knock-in

TUDCA rescue is limited to mouse experiments, and AXV-101 is an early first-in-human safety and dose study. Neither establishes clinical efficacy, and evidence from BBS1 cannot yet be transferred to all five genes.

Show evidence (2 references)

PMID:22110077 SUPPORT Model Organism

"The Rd1 and rd16 mice showed no improvement with TUDCA treatment"

Shows model-dependent response and cautions against class-wide translation.

clinicaltrials:NCT07269665 SUPPORT Human Clinical

"Is AXV-101 safe and tolerable to use in participants with BBS1?"

Confirms that the current human study is framed around safety and tolerability.

⚙

Pathophysiology

4

Partial or retina-selective BBSome dysfunction

Biallelic mild, hypomorphic, or retina-selective alleles reduce BBSome function in photoreceptors. The precise allele mechanism differs by locus: retina-specific splicing is established for TTC8, a visual-function-selective effect for ARL6 p.Ala89Val, a noncoding splice defect for BBS1, missense associations for BBS2, and partial aberrant splicing for BBS9.

ARL6 hgnc:13210 TTC8 hgnc:20087 BBS1 hgnc:966 BBS2 hgnc:967 BBS9 hgnc:30000

protein localization to cilium GO:0061512 ⚠ ABNORMAL

cilium GO:0005929

Downstream

Photoreceptor outer-segment cargo and lipid dysregulation Reduced BBSome function disturbs the composition and homeostasis of the photoreceptor outer segment.

Show evidence (4 references)

PMID:20451172 SUPPORT Human Clinical

"Subsequent studies showed the exon to be expressed exclusively in the retina and enriched significantly in the photoreceptor layer."

Establishes tissue-selective TTC8 transcript use in photoreceptors.

PMID:21282186 SUPPORT Model Organism

"BBS3 A89V is sufficient to rescue the transport delays induced by the loss of bbs3, indicating that this mutation does not affect the function of BBS3 as it relates to syndromic disease."

Shows allele-selective preservation of a general ARL6/BBS3 transport readout.

PMID:33910932 SUPPORT In Vitro

"Functional analysis of the branchpoint variant revealed a complex splicing defect including exon 8 and exon 7/8 skipping, and partial in-frame deletion of exon 8."

Demonstrates a noncoding BBS1 splice defect in isolated RP.

+ 1 more reference

Photoreceptor outer-segment cargo and lipid dysregulation

The photoreceptor outer segment is a specialized cilium with continuous membrane renewal. BBSome loss destabilizes the complex, permits accumulation of membrane-associated cargo, and disrupts lipid and cholesterol composition. Early visual dysfunction can precede overt outer-segment disorganization.

photoreceptor cell CL:0000210

retina UBERON:0000966

Downstream

Progressive rod-first photoreceptor degeneration Persistent outer-segment homeostatic failure leads to progressive photoreceptor degeneration.

Show evidence (1 reference)

PMID:35277505 SUPPORT Model Organism

"Disruption of the tightly regulated OS lipid composition with increased OS cholesterol content are paralleled by early functional visual deficits, which precede progressive OS morphological anomalies."

Establishes a temporal sequence from composition change to dysfunction and structural disease.

Progressive rod-first photoreceptor degeneration

Rod-predominant degeneration produces the characteristic rod-cone electrophysiologic pattern, night blindness, and peripheral field loss. Ongoing disease later compromises cones, macular structure, and central visual acuity.

rod photoreceptor cell CL:0000604 cone photoreceptor cell CL:0000573

retina UBERON:0000966

Downstream

Rod-cone dystrophy Rod-first loss with secondary cone involvement defines the clinical retinal dystrophy.

Nyctalopia Rod dysfunction impairs vision under low-light conditions.

Peripheral visual field loss Progressive rod-rich peripheral retinal disease constricts the visual field.

Abnormal electroretinogram Rod-cone dysfunction reduces or extinguishes full-field ERG responses.

Bone spicule pigmentation Chronic photoreceptor and retinal-pigment-epithelium injury produces characteristic pigment migration.

Secondary cone and macular structural loss Continuing rod-cone degeneration extends to central retinal structure and function.

Show evidence (2 references)

PMID:23143442 SUPPORT Human Clinical

"In patients with electroretinographic responses, a rod-cone pattern of photoreceptor degeneration was observed."

Documents the human rod-cone degeneration pattern.

PMID:37293546 SUPPORT Model Organism

"zebrafish carrying mutations in cep290 or bbs2 undergo progressive loss of cone photoreceptors and exhibit signs of microglia activation and inflammation"

Adds in vivo evidence for progressive photoreceptor loss after BBS2 disruption.

Secondary cone and macular structural loss

Later cone involvement and macular thinning reduce central acuity. Photoreceptor outer-segment loss is visible on OCT, while cystoid macular edema can add a potentially treatable cause of central visual impairment.

cone photoreceptor cell CL:0000573

retina UBERON:0000966

Downstream

Progressive visual loss Progressive central structural loss worsens vision over years.

Visual impairment Macular and cone involvement reduce central visual function.

Photoreceptor outer segment loss on macular OCT Outer-retinal structural loss is visible on macular OCT.

Cystoid macular edema Cystoid macular edema can superimpose additional central visual dysfunction.

Show evidence (1 reference)

PMID:42022048 SUPPORT Human Clinical

"The mean central macular thickness (CMT) at baseline and follow-up was 179.7 ± 43.1 μm and 166.6 ± 50.3 μm."

Shows longitudinal central macular thinning in BBS1 retinopathy.

⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.

●

Phenotypes

9

Eye 6

Rod-cone dystrophy Rod-cone dystrophy HP:0000510

Show evidence (1 reference)

PMID:23143442 SUPPORT Human Clinical

"In patients with electroretinographic responses, a rod-cone pattern of photoreceptor degeneration was observed."

Directly identifies the rod-cone pattern in BBS1-associated RP.

Nyctalopia FREQUENT Nyctalopia HP:0000662

Show evidence (1 reference)

ORPHA:791 SUPPORT Other

"HP:0000662 | Nyctalopia | Frequent (79-30%)"

Provides broad RP frequency support.

Abnormal electroretinogram VERY_FREQUENT Abnormal electroretinogram HP:0000512

Show evidence (2 references)

ORPHA:791 SUPPORT Other

"HP:0000512 | Abnormal electroretinogram | Very frequent (99-80%)"

Provides broad RP frequency support.

PMID:42022048 SUPPORT Human Clinical

"Of the patients who had electrophysiology available, 19 of 27 had rod-cone pattern dysfunction"

Supplies BBS1-specific electrophysiologic data.

Progressive visual loss Progressive visual loss HP:0000529

Show evidence (1 reference)

PMID:42022048 SUPPORT Human Clinical

"The median BCVA was 0.47 logarithm of minimum angle of resolution (LogMAR) (interquartile range 0.3-0.8) at baseline and 1.3 LogMAR (interquartile range 0.7-2.4) at follow-up, with an average decline of 0.05 LogMAR/year."

Quantifies progressive acuity loss in BBS1 retinopathy.

Visual impairment VERY_FREQUENT Visual impairment HP:0000505

Show evidence (1 reference)

ORPHA:791 SUPPORT Other

"HP:0000505 | Visual impairment | Very frequent (99-80%)"

Provides broad RP frequency support.

Photoreceptor outer segment loss on macular OCT FREQUENT Photoreceptor outer segment loss on macular OCT HP:0030610

Show evidence (1 reference)

ORPHA:791 SUPPORT Other

"HP:0030610 | Photoreceptor outer segment loss on macular OCT | Frequent (79-30%)"

Provides broad RP frequency support.

Other 3

Peripheral visual field loss FREQUENT Peripheral visual field loss HP:0007994

Show evidence (1 reference)

ORPHA:791 SUPPORT Other

"HP:0007994 | Peripheral visual field loss | Frequent (79-30%)"

Provides broad RP frequency support.

Bone spicule pigmentation VERY_FREQUENT Spicular pigmentation of the retina HP:0007737

Show evidence (1 reference)

ORPHA:791 SUPPORT Other

"HP:0007737 | Bone spicule pigmentation of the retina | Very frequent (99-80%)"

Provides broad RP frequency support.

Cystoid macular edema FREQUENT Cystoid macular edema HP:0011505

Show evidence (1 reference)

ORPHA:791 SUPPORT Other

"HP:0011505 | Cystoid macular edema | Frequent (79-30%)"

Provides broad RP frequency support.

🧬

Genetic Associations

5

ARL6 (Pathogenic biallelic variants, including the retina-selective p.Ala89Val effect)

Gene: ARL6 hgnc:13210

Show evidence (1 reference)

PMID:21282186 SUPPORT Model Organism

"BBS3L A89V, however, was unable to rescue vision impairment, highlighting a role for a specific amino acid within BBS3 that is necessary for visual function, but dispensable in other cell types."

Connects the ARL6/BBS3 allele to a retina-selective functional deficit.

TTC8 (Pathogenic biallelic variants, including a retina-specific splice allele)

Gene: TTC8 hgnc:20087

Show evidence (2 references)

PMID:20451172 SUPPORT Human Clinical

"an in-frame splice mutation in BBS8, one of the genes involved in pleiotropic Bardet-Biedl syndrome (BBS), is sufficient to cause nonsyndromic retinitis pigmentosa (RP)"

Establishes a retina-specific TTC8/BBS8 allele as the cause of RP51.

PMID:26195043 SUPPORT Human Clinical

"This mutation segregated completely with the disease in the family and was not observed in 100 ethnically matched controls from same population."

Adds segregation evidence from an independent TTC8-RP51 family.

BBS1 (Pathogenic biallelic variants at the mild end of the BBS1 allelic spectrum)

Gene: BBS1 hgnc:966

Show evidence (2 references)

PMID:23143442 SUPPORT Human Clinical

"The 14 patients with 2 BBS1 variants showed the entire clinical spectrum, from nonsyndromic RP to full-blown BBS."

Establishes isolated RP as one end of the BBS1 allelic spectrum.

PMID:33910932 SUPPORT Human Clinical

"A putative severe branchpoint variant in BBS1, together with a mild missense variant, underlies non-syndromic RP in four unrelated individuals."

Replicates BBS1-associated isolated RP and adds a noncoding pathogenic mechanism.

BBS2 (Pathogenic biallelic variants, especially reported missense combinations)

Gene: BBS2 hgnc:967

Show evidence (2 references)

PMID:25541840 SUPPORT Human Clinical

"In total, we identified 4 BBS2 missense mutations that cause nonsyndromic retinitis pigmentosa."

Establishes multiple BBS2 missense alleles in nonsyndromic RP families.

PMID:37031301 SUPPORT Human Clinical

"Patients with biallelic missense variants in BBS2 suffered fewer clinical symptoms and mild visual impairment."

Supports reduced systemic burden with some biallelic BBS2 missense genotypes.

BBS9 (Pathogenic biallelic variants, including a hypomorphic splice-affecting allele)

Gene: BBS9 hgnc:30000

Show evidence (2 references)

PMID:22353939 SUPPORT Human Clinical

"including the occurrence of nonsyndromic retinitis pigmentosa in a family with a novel BBS9 mutation"

Documents a BBS9-associated nonsyndromic-RP family.

PMID:38534779 SUPPORT Human Clinical

"we suggest that this variant is likely hypomorphic. This is in agreement with the relatively mild phenotype observed in the patient."

Relates partial splice disruption to a mild, retina-dominant BBS9 phenotype.

💊

Medical Actions

3

Low-vision rehabilitation and adaptive support

Action: supportive care Ontology label: Supportive Care NCIT:C15747

Magnification, contrast and lighting optimization, orientation and mobility training, educational or workplace accommodations, and assistive technology are individualized as acuity and field loss progress.

Target Phenotypes: Progressive visual loss HP:0000529 Peripheral visual field loss HP:0007994

Show evidence (1 reference)

ORPHA:791 SUPPORT Other

"Retinitis pigmentosa (RP) is an inherited retinal dystrophy leading to progressive loss of the photoreceptors and retinal pigment epithelium and resulting in blindness usually after several decades."

The progressive functional burden supports continuing rehabilitative care.

Ophthalmic surveillance and complication management

Action: eye examination Ontology label: Eye Examination NCIT:C38060

Serial acuity, visual-field, OCT, and examination assessments document progression and detect potentially treatable contributors such as cystoid macular edema or cataract. Management should be individualized by a retinal specialist; surveillance is not a disease-modifying treatment.

Target Phenotypes: Cystoid macular edema HP:0011505 Progressive visual loss HP:0000529

Show evidence (2 references)

PMID:42022048 SUPPORT Human Clinical

"Retinal imaging and electrophysiology were analyzed cross-sectionally and longitudinally."

Supports longitudinal multimodal retinal assessment.

ORPHA:791 SUPPORT Other

"HP:0011505 | Cystoid macular edema | Frequent (79-30%)"

Establishes a common retinal complication that surveillance can detect.

Genetic counseling

Action: genetic counseling Ontology label: Genetic Counseling NCIT:C15240

Counseling addresses autosomal recessive recurrence, carrier testing, reproductive options, the gene-specific allelic spectrum, and uncertainty about later systemic BBS manifestations. Molecularly confirmed relatives should receive phenotype-appropriate evaluation.

Show evidence (1 reference)

PMID:37031301 SUPPORT Human Clinical

"Genetic analysis is therefore crucial for diagnosis, genetic counseling, and future gene therapy in these patients."

Directly supports genetic counseling in BBS-gene retinal disease.

🔀

Differential Diagnoses

3

Conditions with similar clinical presentations that must be differentiated from BBSome-related retinitis pigmentosa:

Bardet-Biedl syndrome

Overlapping Features Full or mild BBS shares the same genes and retinal mechanism. Obesity, polydactyly, renal or genitourinary disease, neurodevelopmental findings, and other extra-ocular features favor syndromic classification; absence at one visit may reflect age or mild expressivity.

Distinguishing Features

Multisystem involvement rather than retina-dominant disease
Systemic surveillance may reveal age-dependent features

Show evidence (1 reference)

PMID:37031301 SUPPORT Human Clinical

"The patients exhibited clinical heterogeneity, from patients with all six primary clinical components to patients suffering from non-syndromic RP."

Directly establishes the syndromic-to-isolated spectrum.

Nonsyndromic retinitis pigmentosa from non-BBSome genes

Overlapping Features Many phototransduction, outer-segment, retinoid-cycle, splicing, and other ciliary genes can produce an indistinguishable rod-cone dystrophy. Molecular diagnosis, rather than retinal appearance alone, identifies this BBSome class.

Distinguishing Features

Pathogenic variants in another RP gene
No BBSome-gene allelic explanation

Show evidence (1 reference)

PMID:33910932 SUPPORT Human Clinical

"Inherited retinal diseases (IRDs) can be caused by variants in >270 genes."

Establishes the extensive genetic differential for inherited retinal disease.

Other syndromic retinal ciliopathies

Overlapping Features Alström, Senior-Løken, Joubert, and other ciliary disorders may combine retinal degeneration with renal, neurologic, metabolic, hearing, or skeletal findings. Broader phenotype and non-BBSome molecular results distinguish them.

Distinguishing Features

Syndrome-specific extra-ocular findings
Causal variants outside the five-gene BBSome-RP scope

Show evidence (1 reference)

PMID:37293546 SUPPORT Other

"The mutations in ciliopathy genes disrupt distinct components of the cilium, yet all cause retinal degeneration."

Supports mechanistically distinct ciliopathies as retinal-degeneration differentials.

📊

Related Datasets

2

Bbs8-deficient mouse retinal pigment epithelium transcriptomics geo:GSE144847

GEO SuperSeries containing P11 and P29 Bbs8-knockout versus wild-type mouse RPE expression studies (subseries GSE144845 and GSE144846), associated with the published RPE transcriptomic and proteomic analysis.

mouse BULK RNA SEQ

Conditions: Bbs8 knockout retinal pigment epithelium Wild-type retinal pigment epithelium

PMID:33681195

Show evidence (1 reference)

PMID:33681195 SUPPORT Model Organism

"We demonstrate that upon loss of Bbs8, predominantly thought to be a ciliary gene, the RPE shows changes in gene and protein expression initially involved in signaling pathways and developmental processes"

Describes molecular profiling of Bbs8-deficient retinal pigment epithelium.

bbs2-mutant zebrafish retina RNA sequencing geo:GSE223277

Bulk retinal RNA-seq comparing adult bbs2-mutant, cep290-mutant, and wild-type zebrafish during photoreceptor degeneration.

zebrafish BULK RNA SEQ

Conditions: bbs2 homozygous mutant retina cep290 homozygous mutant retina Wild-type retina

PMID:37293546

Show evidence (1 reference)

PMID:37293546 SUPPORT Model Organism

"RNA-seq transcriptional profiling was performed on cep290-/- and bbs2-/- retinas."

Directly identifies the mutant-retina bulk RNA-seq experiment.

🔬

Clinical Trials

1

NCT07269665 PHASE_I NOT_RECRUITING

First-in-human, open-label, dose-escalation study of a single intraocular AXV-101 dose in participants aged 4-17 years with biallelic BBS1 variants and retinal degeneration. The study evaluates preliminary safety, tolerability, dose, pharmacodynamics, ocular structural and functional change, and systemic pharmacokinetics; it does not establish efficacy.

Target Phenotypes: Rod-cone dystrophy HP:0000510 Progressive visual loss HP:0000529

Show evidence (1 reference)

clinicaltrials:NCT07269665 SUPPORT Human Clinical

"The goal of this first in human study is to evaluate the preliminary safety and tolerability of AXV-101 in participants with BBS1."

Identifies the first-in-human BBS1 retinal gene-therapy safety study.

🧫

Experimental Models

2

KCi001-A BBS1 patient-derived induced pluripotent stem cell line CELL_LINE

A patient-derived pluripotent resource carrying BBS1 p.Met390Arg and p.Gly370Arg. The donor had Bardet-Biedl syndrome rather than confirmed isolated RP, and the undifferentiated line is a platform for downstream retinal differentiation rather than a validated retinal phenotype model.

Organism

human NCBITaxon:9606

Cell source

Peripheral-cell-derived iPSC from a patient with compound-heterozygous BBS1 variants

Publication

PMID:30142598

Show evidence (1 reference)

PMID:30142598 SUPPORT In Vitro

"Here we describe the successful generation of an induced pluripotent stem cell (iPSC) KCi001-A from a BBS patient compound heterozygous for two disease causing BBS1 variants"

Establishes the genotype-defined human iPSC resource.

IBMS-iPSC-063-06 BBS2 patient-derived induced pluripotent stem cell line CELL_LINE

A pluripotent human resource retaining the BBS2 c.534+1G>T variant. The donor had syndromic BBS, so this resource models BBS2 loss in a human background but is not evidence for isolated RP.

Organism

human NCBITaxon:9606

Cell source

Patient-derived iPSC carrying a homozygous BBS2 splice variant

Publication

PMID:34364070

Show evidence (1 reference)

PMID:34364070 SUPPORT In Vitro

"We reported the generation and characterization of an iPS cell line, IBMS-iPSC-063-06, from a patient carrying the BBS2 homologous c534 + 1G > T mutation."

Establishes the genotype-defined human BBS2 iPSC resource.

{ }

Source YAML

click to show

name: BBSome-related retinitis pigmentosa
creation_date: "2026-06-14T00:00:00Z"
updated_date: "2026-07-23T00:00:00Z"
category: Mendelian
description: >-
  BBSome-related retinitis pigmentosa is a mechanism-anchored class of
  autosomal recessive, predominantly isolated rod-cone dystrophy caused by
  biallelic variants in genes encoding the BBSome or its membrane-recruiting
  GTPase. The supported loci in this entry are ARL6/BBS3 (RP55), TTC8/BBS8
  (RP51), BBS1, BBS2, and BBS9. Retina-restricted splice isoforms, hypomorphic
  alleles, and other mild allelic combinations can reduce BBSome function enough
  to disturb photoreceptor-cilium cargo and outer-segment homeostasis while
  producing few or no extra-ocular Bardet-Biedl manifestations at ascertainment.
  Rod dysfunction, nyctalopia, and peripheral field loss generally precede
  central visual decline. The boundary with Bardet-Biedl syndrome is
  age-dependent and allelic rather than absolute, so ongoing systemic review is
  appropriate. No exact MONDO term represents this five-gene mechanistic lump;
  MONDO:0019200 is used as the broad disease term and per-locus entities are
  retained as related mappings.
disease_term:
  preferred_term: BBSome-related retinitis pigmentosa
  term:
    id: MONDO:0019200
    label: retinitis pigmentosa
parents:
- Ciliopathy
- Retinitis pigmentosa
synonyms:
- BBSome-machine nonsyndromic retinitis pigmentosa
- BBSome-associated isolated retinal dystrophy
- BBSome-related rod-cone dystrophy
classifications:
  harrisons_chapter:
  - classification_value: GENETICS_ENVIRONMENT_DISEASE
    evidence:
    - reference: PMID:37031301
      reference_title: Phenotypic diversity observed in a Chinese patient cohort with biallelic variants in Bardet-Biedl syndrome genes.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        We recruited 34 patients from 31 unrelated pedigrees who carried
        biallelic pathogenic variants in BBS genes.
      explanation: Supports classification as a biallelic inherited disorder.
  mechanistic_category:
  - classification_value: ciliopathy
    evidence:
    - reference: PMID:22353939
      reference_title: In search of triallelism in Bardet-Biedl syndrome.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Bardet-Biedl syndrome (BBS) is a model disease for ciliopathy in humans."
      explanation: Places BBS-gene disease in the ciliopathy category.
mappings:
  mondo_mappings:
  - term:
      id: MONDO:0013312
      label: retinitis pigmentosa 55
    mapping_predicate: skos:relatedMatch
    mapping_source: MONDO
    mapping_justification: ARL6/BBS3 per-locus isolated-RP entity federated by this mechanistic class.
  - term:
      id: MONDO:1040065
      label: ARL6-related ciliopathy
    mapping_predicate: skos:relatedMatch
    mapping_source: MONDO
    mapping_justification: ARL6 allelic-series entity spanning isolated retinal disease and syndromic ciliopathy.
  - term:
      id: MONDO:0013274
      label: retinitis pigmentosa 51
    mapping_predicate: skos:relatedMatch
    mapping_source: MONDO
    mapping_justification: TTC8/BBS8 per-locus isolated-RP entity federated by this mechanistic class.
  - term:
      id: MONDO:1040049
      label: TTC8-related ciliopathy
    mapping_predicate: skos:relatedMatch
    mapping_source: MONDO
    mapping_justification: TTC8 allelic-series entity spanning isolated retinal disease and syndromic ciliopathy.
  - term:
      id: MONDO:1040043
      label: BBS1-related ciliopathy
    mapping_predicate: skos:relatedMatch
    mapping_source: MONDO
    mapping_justification: BBS1 allelic-series entity spanning isolated retinopathy and Bardet-Biedl syndrome.
  - term:
      id: MONDO:1040048
      label: BBS2-related ciliopathy
    mapping_predicate: skos:relatedMatch
    mapping_source: MONDO
    mapping_justification: BBS2 allelic-series entity spanning isolated retinopathy and Bardet-Biedl syndrome.
  - term:
      id: MONDO:0700236
      label: BBS9-related ciliopathy
    mapping_predicate: skos:relatedMatch
    mapping_source: MONDO
    mapping_justification: BBS9 allelic-series entity spanning isolated retinal disease and syndromic ciliopathy.
external_assertions:
- name: Orphanet retinitis pigmentosa record
  source: Orphanet
  assertion_type: structured_disease_record
  external_id: ORPHA:791
  url: https://www.orpha.net/en/disease/detail/791
  description: >-
    The Orphanet RP record supplies the broad retinal-dystrophy definition,
    natural-history range, phenotype frequencies, and ARL6, BBS1, BBS2, and
    TTC8 gene associations. It is broader than this BBSome-specific class.
  evidence:
  - reference: ORPHA:791
    reference_title: Retinitis pigmentosa
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Retinitis pigmentosa (RP) is an inherited retinal dystrophy leading to
      progressive loss of the photoreceptors and retinal pigment epithelium and
      resulting in blindness usually after several decades.
    explanation: Provides the authoritative broad RP definition used for this mapped class.
- name: ClinGen ARL6-related ciliopathy validity assertion
  source: ClinGen Gene-Disease Validity
  assertion_type: gene_disease_validity
  external_id: assertion_9289028a-10d0-4d9a-aa17-13d13d91c732-2025-07-14T160000.000Z
  url: https://search.clinicalgenome.org/kb/gene-validity
  description: >-
    The pinned ClinGen snapshot classifies ARL6 for the broader ARL6-related
    ciliopathy entity. The assertion is contextual support and is not treated as
    a validity grade for the narrower isolated-RP association.
  evidence:
  - reference: PMID:21282186
    reference_title: Functional analysis of BBS3 A89V that results in non-syndromic retinal degeneration.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      homozygosity mapping with a consanguineous family with isolated retinitis
      pigmentosa identified a missense mutation in BBS3, a known BBS gene
    explanation: Independently anchors the precise ARL6/BBS3 isolated-RP association.
- name: ClinGen TTC8-related ciliopathy validity assertion
  source: ClinGen Gene-Disease Validity
  assertion_type: gene_disease_validity
  external_id: assertion_1ac205a8-bf9d-4c54-8d1c-c5d3af4b4aab-2024-06-06T160000.000Z
  url: https://search.clinicalgenome.org/kb/gene-validity
  description: >-
    The pinned ClinGen snapshot classifies TTC8 for the broader TTC8-related
    ciliopathy entity. The narrower RP51 association is supported separately by
    the human pedigrees cited in this entry.
  evidence:
  - reference: PMID:26195043
    reference_title: Confirmation of TTC8 as a disease gene for nonsyndromic autosomal recessive retinitis pigmentosa (RP51).
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      This represents second report of a TTC8 mutation in nonsyndromic RP, thus
      confirming the identity of TTC8 as causative gene for RP51.
    explanation: Provides independent replication of the TTC8-RP51 association.
- name: ClinGen BBS1-related ciliopathy validity assertion
  source: ClinGen Gene-Disease Validity
  assertion_type: gene_disease_validity
  external_id: assertion_ee6e7562-927a-459b-a0f1-ccd849c7e783-2023-12-07T170000.000Z
  url: https://search.clinicalgenome.org/kb/gene-validity
  description: >-
    The pinned ClinGen snapshot classifies BBS1 for the broader BBS1-related
    ciliopathy entity. It does not substitute for isolated-retinopathy evidence.
  evidence:
  - reference: PMID:23143442
    reference_title: BBS1 mutations in a wide spectrum of phenotypes ranging from nonsyndromic retinitis pigmentosa to Bardet-Biedl syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The 14 patients with 2 BBS1 variants showed the entire clinical spectrum,
      from nonsyndromic RP to full-blown BBS.
    explanation: Demonstrates the BBS1 allelic spectrum that includes nonsyndromic RP.
- name: ClinGen BBS2-related ciliopathy validity assertion
  source: ClinGen Gene-Disease Validity
  assertion_type: gene_disease_validity
  external_id: assertion_be74a060-cfb3-4180-a107-cfaf0e81bfa3-2024-03-07T170000.000Z
  url: https://search.clinicalgenome.org/kb/gene-validity
  description: >-
    The pinned ClinGen snapshot classifies BBS2 for the broader BBS2-related
    ciliopathy entity. The narrower nonsyndromic-RP evidence is kept distinct.
  evidence:
  - reference: PMID:25541840
    reference_title: Association between missense mutations in the BBS2 gene and nonsyndromic retinitis pigmentosa.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Our study shows that BBS2 mutations can cause nonsyndromic retinitis
      pigmentosa and highlights yet another candidate for this genetically
      heterogeneous condition.
    explanation: Directly supports BBS2-associated nonsyndromic RP.
- name: ClinGen BBS9-related ciliopathy validity assertion
  source: ClinGen Gene-Disease Validity
  assertion_type: gene_disease_validity
  external_id: assertion_3fc68f9f-ed7c-453e-8c41-179a9ccad0ca-2023-08-03T160000.000Z
  url: https://search.clinicalgenome.org/kb/gene-validity
  description: >-
    The pinned ClinGen snapshot classifies BBS9 for the broader BBS9-related
    ciliopathy entity. The isolated or nearly isolated retinal presentation is
    supported by primary reports below.
  evidence:
  - reference: PMID:38534779
    reference_title: Autosomal Recessive Rod-Cone Dystrophy with Mild Extra-Ocular Manifestations Due to a Splice-Affecting Variant in BBS9.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      variants in this gene should be considered not only in BBS patients but
      also in individuals with non-syndromic IRD or IRD with very mild
      extra-ocular manifestations.
    explanation: Supports the retinally restricted end of the BBS9 allelic spectrum.
definitions:
- name: Broad retinitis pigmentosa definition
  definition_type: OTHER
  description: >-
    An inherited retinal dystrophy with progressive photoreceptor and retinal
    pigment epithelium loss, usually leading to severe visual impairment over
    decades.
  evidence:
  - reference: ORPHA:791
    reference_title: Retinitis pigmentosa
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Retinitis pigmentosa (RP) is an inherited retinal dystrophy leading to
      progressive loss of the photoreceptors and retinal pigment epithelium and
      resulting in blindness usually after several decades.
    explanation: Defines the broad RP phenotype represented by MONDO:0019200.
- name: BBSome-related isolated-RP scope
  definition_type: OTHER
  description: >-
    This entry includes only well-documented isolated or nearly isolated RP at
    ARL6, TTC8, BBS1, BBS2, and BBS9. Other BBS genes remain outside the lump
    until primary human evidence establishes a comparable presentation, and
    non-BBSome ciliary genes such as IFT172 and CFAP418 remain outside its
    mechanistic boundary.
  evidence:
  - reference: PMID:37031301
    reference_title: Phenotypic diversity observed in a Chinese patient cohort with biallelic variants in Bardet-Biedl syndrome genes.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Diagnosis of BBS and non-syndromic retinitis pigmentosa (RP) were
      established in 28 patients from 27 pedigrees and 6 patients, respectively.
    explanation: Confirms that nonsyndromic RP occurs within BBS-gene cohorts without making it universal.
notes: >-
  Evidence is intentionally partitioned. Each locus-to-isolated-RP association
  is supported by its own human report; the shared trafficking mechanism is
  supported by conformance to the bbsome_trafficking and
  photoreceptor_degeneration modules plus experimental studies. The five ClinGen
  assertions are for broader gene-specific ciliopathies and are not imported as
  isolated-RP validity grades. “Isolated” means no defining systemic BBS burden
  was recognized at the reported assessment; it does not guarantee lifelong
  absence. LZTFL1 and IFT27 are dedicated BBSome operators but lack adequate
  primary evidence for inclusion in this isolated-RP class. IFT172, CFAP418, and
  transition-zone or IFT-B disorders are mechanistically adjacent but out of
  scope.
inheritance:
- name: Autosomal recessive inheritance
  inheritance_term:
    preferred_term: Autosomal recessive inheritance
    term:
      id: HP:0000007
      label: Autosomal recessive inheritance
  description: >-
    The supported BBSome-related isolated-RP presentations result from biallelic
    pathogenic variants. Apparent modifier effects can alter expressivity, but
    the primary inheritance model remains autosomal recessive.
  evidence:
  - reference: PMID:23143442
    reference_title: BBS1 mutations in a wide spectrum of phenotypes ranging from nonsyndromic retinitis pigmentosa to Bardet-Biedl syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Variants in BBS1 are significantly associated with nonsyndromic autosomal
      recessive RP and relatively mild forms of BBS.
    explanation: Directly documents autosomal recessive BBS1-associated nonsyndromic RP.
  - reference: PMID:22353939
    reference_title: In search of triallelism in Bardet-Biedl syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      our study argues in favor of straightforward autosomal recessive BBS in
      most cases.
    explanation: Supports a primary recessive rather than triallelic inheritance model.
progression:
- phase: Onset
  age_range: Childhood, adolescence, or adulthood
  notes: >-
    Onset varies between genes and alleles. The broad RP record spans childhood
    through adulthood; hypomorphic BBS1 p.Met390Arg is associated with later
    onset than other BBS1 genotypes.
  evidence:
  - reference: ORPHA:791
    reference_title: Retinitis pigmentosa
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Age of onset: Childhood"
    explanation: Orphanet includes childhood among the documented RP onset categories.
  - reference: PMID:42022048
    reference_title: Genetic and Phenotypic Characterization of a Large Cohort of Patients with BBS1-Retinopathy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      homozygous patients for the most common variant p.(Met390Arg) had an older
      age of onset and reached legal blindness at an older age compared with the
      other genotypes.
    explanation: Provides genotype-specific onset and severity information for BBS1 retinopathy.
- phase: Progressive rod-cone and macular degeneration
  age_range: Years to decades after onset
  notes: >-
    Night vision and peripheral field function decline as rod disease advances;
    cone and macular structural loss later reduce central acuity. Rates from the
    BBS1 cohort should not be assumed for every gene in this lump.
  evidence:
  - reference: PMID:42022048
    reference_title: Genetic and Phenotypic Characterization of a Large Cohort of Patients with BBS1-Retinopathy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The median BCVA was 0.47 logarithm of minimum angle of resolution (LogMAR)
      (interquartile range 0.3-0.8) at baseline and 1.3 LogMAR (interquartile
      range 0.7-2.4) at follow-up, with an average decline of 0.05 LogMAR/year.
    explanation: Quantifies longitudinal visual-acuity decline in molecularly confirmed BBS1 retinopathy.
  - reference: PMID:42022048
    reference_title: Genetic and Phenotypic Characterization of a Large Cohort of Patients with BBS1-Retinopathy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The rate of decline for CMT and ONLT was 4.2 μm and 1.7 μm per year,
      respectively.
    explanation: Quantifies progressive macular and outer-nuclear-layer thinning in the BBS1 cohort.
genetic:
- name: ARL6
  association: Pathogenic biallelic variants, including the retina-selective p.Ala89Val effect
  gene_term:
    preferred_term: ARL6
    term:
      id: hgnc:13210
      label: ARL6
  notes: >-
    ARL6/BBS3 is the small GTPase that recruits the BBSome to ciliary membranes.
    The p.Ala89Val report implicates a visual role of the BBS3L isoform while
    sparing a transport function tested in zebrafish; the isolated-RP
    association is based on limited-family evidence.
  evidence:
  - reference: PMID:21282186
    reference_title: Functional analysis of BBS3 A89V that results in non-syndromic retinal degeneration.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      BBS3L A89V, however, was unable to rescue vision impairment, highlighting
      a role for a specific amino acid within BBS3 that is necessary for visual
      function, but dispensable in other cell types.
    explanation: Connects the ARL6/BBS3 allele to a retina-selective functional deficit.
- name: TTC8
  association: Pathogenic biallelic variants, including a retina-specific splice allele
  gene_term:
    preferred_term: TTC8
    term:
      id: hgnc:20087
      label: TTC8
  notes: >-
    TTC8/BBS8 is a core BBSome subunit. A splice-site variant in a
    retina-specific exon established RP51, and a second pedigree with a distinct
    TTC8 variant independently confirmed the gene-disease relationship.
  evidence:
  - reference: PMID:20451172
    reference_title: A splice-site mutation in a retina-specific exon of BBS8 causes nonsyndromic retinitis pigmentosa.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      an in-frame splice mutation in BBS8, one of the genes involved in
      pleiotropic Bardet-Biedl syndrome (BBS), is sufficient to cause
      nonsyndromic retinitis pigmentosa (RP)
    explanation: Establishes a retina-specific TTC8/BBS8 allele as the cause of RP51.
  - reference: PMID:26195043
    reference_title: Confirmation of TTC8 as a disease gene for nonsyndromic autosomal recessive retinitis pigmentosa (RP51).
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      This mutation segregated completely with the disease in the family and was
      not observed in 100 ethnically matched controls from same population.
    explanation: Adds segregation evidence from an independent TTC8-RP51 family.
- name: BBS1
  association: Pathogenic biallelic variants at the mild end of the BBS1 allelic spectrum
  gene_term:
    preferred_term: BBS1
    term:
      id: hgnc:966
      label: BBS1
  notes: >-
    BBS1 is a core BBSome subunit. Recurrent p.Met390Arg can occur in isolated
    RP, mild BBS, or full BBS, and a noncoding branchpoint allele paired with
    p.Met390Arg demonstrates why coding-only testing may miss a causal allele.
  evidence:
  - reference: PMID:23143442
    reference_title: BBS1 mutations in a wide spectrum of phenotypes ranging from nonsyndromic retinitis pigmentosa to Bardet-Biedl syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The 14 patients with 2 BBS1 variants showed the entire clinical spectrum,
      from nonsyndromic RP to full-blown BBS.
    explanation: Establishes isolated RP as one end of the BBS1 allelic spectrum.
  - reference: PMID:33910932
    reference_title: BBS1 branchpoint variant is associated with non-syndromic retinitis pigmentosa.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A putative severe branchpoint variant in BBS1, together with a mild
      missense variant, underlies non-syndromic RP in four unrelated individuals.
    explanation: Replicates BBS1-associated isolated RP and adds a noncoding pathogenic mechanism.
- name: BBS2
  association: Pathogenic biallelic variants, especially reported missense combinations
  gene_term:
    preferred_term: BBS2
    term:
      id: hgnc:967
      label: BBS2
  notes: >-
    Multiple cosegregating BBS2 missense genotypes have been reported in
    nonsyndromic RP families. A later BBS-gene cohort also linked biallelic
    missense BBS2 variants with fewer systemic findings and milder visual
    impairment.
  evidence:
  - reference: PMID:25541840
    reference_title: Association between missense mutations in the BBS2 gene and nonsyndromic retinitis pigmentosa.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In total, we identified 4 BBS2 missense mutations that cause
      nonsyndromic retinitis pigmentosa.
    explanation: Establishes multiple BBS2 missense alleles in nonsyndromic RP families.
  - reference: PMID:37031301
    reference_title: Phenotypic diversity observed in a Chinese patient cohort with biallelic variants in Bardet-Biedl syndrome genes.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Patients with biallelic missense variants in BBS2 suffered fewer clinical
      symptoms and mild visual impairment.
    explanation: Supports reduced systemic burden with some biallelic BBS2 missense genotypes.
- name: BBS9
  association: Pathogenic biallelic variants, including a hypomorphic splice-affecting allele
  gene_term:
    preferred_term: BBS9
    term:
      id: hgnc:30000
      label: BBS9
  notes: >-
    A family with nonsyndromic RP and a novel BBS9 variant was reported in a
    BBS cohort. A subsequent patient with a splice-affecting allele had
    rod-cone dystrophy and only mild extra-ocular findings; this entry represents
    the phenotype as nearly isolated rather than asserting complete absence of
    systemic disease.
  evidence:
  - reference: PMID:22353939
    reference_title: In search of triallelism in Bardet-Biedl syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      including the occurrence of nonsyndromic retinitis pigmentosa in a family
      with a novel BBS9 mutation
    explanation: Documents a BBS9-associated nonsyndromic-RP family.
  - reference: PMID:38534779
    reference_title: Autosomal Recessive Rod-Cone Dystrophy with Mild Extra-Ocular Manifestations Due to a Splice-Affecting Variant in BBS9.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      we suggest that this variant is likely hypomorphic. This is in agreement
      with the relatively mild phenotype observed in the patient.
    explanation: Relates partial splice disruption to a mild, retina-dominant BBS9 phenotype.
pathophysiology:
- name: Partial or retina-selective BBSome dysfunction
  conforms_to: "bbsome_trafficking#BBSome-Dependent Ciliary Cargo Trafficking Failure"
  description: >-
    Biallelic mild, hypomorphic, or retina-selective alleles reduce BBSome
    function in photoreceptors. The precise allele mechanism differs by locus:
    retina-specific splicing is established for TTC8, a visual-function-selective
    effect for ARL6 p.Ala89Val, a noncoding splice defect for BBS1, missense
    associations for BBS2, and partial aberrant splicing for BBS9.
  genes:
  - preferred_term: ARL6
    term:
      id: hgnc:13210
      label: ARL6
  - preferred_term: TTC8
    term:
      id: hgnc:20087
      label: TTC8
  - preferred_term: BBS1
    term:
      id: hgnc:966
      label: BBS1
  - preferred_term: BBS2
    term:
      id: hgnc:967
      label: BBS2
  - preferred_term: BBS9
    term:
      id: hgnc:30000
      label: BBS9
  cellular_components:
  - preferred_term: cilium
    term:
      id: GO:0005929
      label: cilium
  biological_processes:
  - preferred_term: protein localization to cilium
    term:
      id: GO:0061512
      label: protein localization to cilium
    modifier: ABNORMAL
  evidence:
  - reference: PMID:20451172
    reference_title: A splice-site mutation in a retina-specific exon of BBS8 causes nonsyndromic retinitis pigmentosa.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Subsequent studies showed the exon to be expressed exclusively in the
      retina and enriched significantly in the photoreceptor layer.
    explanation: Establishes tissue-selective TTC8 transcript use in photoreceptors.
  - reference: PMID:21282186
    reference_title: Functional analysis of BBS3 A89V that results in non-syndromic retinal degeneration.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      BBS3 A89V is sufficient to rescue the transport delays induced by the loss
      of bbs3, indicating that this mutation does not affect the function of
      BBS3 as it relates to syndromic disease.
    explanation: Shows allele-selective preservation of a general ARL6/BBS3 transport readout.
  - reference: PMID:33910932
    reference_title: BBS1 branchpoint variant is associated with non-syndromic retinitis pigmentosa.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Functional analysis of the branchpoint variant revealed a complex
      splicing defect including exon 8 and exon 7/8 skipping, and partial
      in-frame deletion of exon 8.
    explanation: Demonstrates a noncoding BBS1 splice defect in isolated RP.
  - reference: PMID:38534779
    reference_title: Autosomal Recessive Rod-Cone Dystrophy with Mild Extra-Ocular Manifestations Due to a Splice-Affecting Variant in BBS9.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      An in vitro minigene splice assay demonstrated that this variant leads to
      the partial aberrant splicing of Exon 3.
    explanation: Demonstrates partial splice disruption for a mild BBS9 retinal phenotype.
  downstream:
  - target: Photoreceptor outer-segment cargo and lipid dysregulation
    description: Reduced BBSome function disturbs the composition and homeostasis of the photoreceptor outer segment.
    evidence:
    - reference: PMID:35277505
      reference_title: Loss of the Bardet-Biedl protein Bbs1 alters photoreceptor outer segment protein and lipid composition.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        Bbs1-loss leads to accumulation of membrane-associated proteins in OSs,
        with enrichment in proteins involved in lipid homeostasis.
      explanation: Directly links BBSome loss to outer-segment cargo and lipid disturbance.
- name: Photoreceptor outer-segment cargo and lipid dysregulation
  description: >-
    The photoreceptor outer segment is a specialized cilium with continuous
    membrane renewal. BBSome loss destabilizes the complex, permits accumulation
    of membrane-associated cargo, and disrupts lipid and cholesterol composition.
    Early visual dysfunction can precede overt outer-segment disorganization.
  cell_types:
  - preferred_term: photoreceptor cell
    term:
      id: CL:0000210
      label: photoreceptor cell
  locations:
  - preferred_term: retina
    term:
      id: UBERON:0000966
      label: retina
  evidence:
  - reference: PMID:35277505
    reference_title: Loss of the Bardet-Biedl protein Bbs1 alters photoreceptor outer segment protein and lipid composition.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Disruption of the tightly regulated OS lipid composition with increased
      OS cholesterol content are paralleled by early functional visual deficits,
      which precede progressive OS morphological anomalies.
    explanation: Establishes a temporal sequence from composition change to dysfunction and structural disease.
  downstream:
  - target: Progressive rod-first photoreceptor degeneration
    description: Persistent outer-segment homeostatic failure leads to progressive photoreceptor degeneration.
    evidence:
    - reference: PMID:35277505
      reference_title: Loss of the Bardet-Biedl protein Bbs1 alters photoreceptor outer segment protein and lipid composition.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        Our findings identify a role for Bbs1/BBSome in OS lipid homeostasis,
        suggesting a pathomechanism underlying retinal degeneration in BBS.
      explanation: Connects BBSome-dependent outer-segment homeostasis to retinal degeneration.
- name: Progressive rod-first photoreceptor degeneration
  conforms_to: "photoreceptor_degeneration#Rod Photoreceptor Apoptosis"
  description: >-
    Rod-predominant degeneration produces the characteristic rod-cone
    electrophysiologic pattern, night blindness, and peripheral field loss.
    Ongoing disease later compromises cones, macular structure, and central
    visual acuity.
  cell_types:
  - preferred_term: rod photoreceptor cell
    term:
      id: CL:0000604
      label: retinal rod cell
  - preferred_term: cone photoreceptor cell
    term:
      id: CL:0000573
      label: retinal cone cell
  locations:
  - preferred_term: retina
    term:
      id: UBERON:0000966
      label: retina
  evidence:
  - reference: PMID:23143442
    reference_title: BBS1 mutations in a wide spectrum of phenotypes ranging from nonsyndromic retinitis pigmentosa to Bardet-Biedl syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In patients with electroretinographic responses, a rod-cone pattern of
      photoreceptor degeneration was observed.
    explanation: Documents the human rod-cone degeneration pattern.
  - reference: PMID:37293546
    reference_title: Comparative analysis of transcriptional changes in zebrafish cep290 and bbs2 mutants by RNA-seq reveals upregulation of inflammatory and stress-related pathways.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      zebrafish carrying mutations in cep290 or bbs2 undergo progressive loss
      of cone photoreceptors and exhibit signs of microglia activation and
      inflammation
    explanation: Adds in vivo evidence for progressive photoreceptor loss after BBS2 disruption.
  downstream:
  - target: Rod-cone dystrophy
    description: Rod-first loss with secondary cone involvement defines the clinical retinal dystrophy.
    evidence:
    - reference: PMID:23143442
      reference_title: BBS1 mutations in a wide spectrum of phenotypes ranging from nonsyndromic retinitis pigmentosa to Bardet-Biedl syndrome.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        In patients with electroretinographic responses, a rod-cone pattern of
        photoreceptor degeneration was observed.
      explanation: Directly supports the rod-cone dystrophy phenotype.
  - target: Nyctalopia
    description: Rod dysfunction impairs vision under low-light conditions.
    evidence:
    - reference: ORPHA:791
      reference_title: Retinitis pigmentosa
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "HP:0000662 | Nyctalopia | Frequent (79-30%)"
      explanation: Records nyctalopia as a frequent RP phenotype.
  - target: Peripheral visual field loss
    description: Progressive rod-rich peripheral retinal disease constricts the visual field.
    evidence:
    - reference: ORPHA:791
      reference_title: Retinitis pigmentosa
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "HP:0007994 | Peripheral visual field loss | Frequent (79-30%)"
      explanation: Records peripheral field loss as a frequent RP phenotype.
  - target: Abnormal electroretinogram
    description: Rod-cone dysfunction reduces or extinguishes full-field ERG responses.
    evidence:
    - reference: ORPHA:791
      reference_title: Retinitis pigmentosa
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "HP:0000512 | Abnormal electroretinogram | Very frequent (99-80%)"
      explanation: Records abnormal ERG as a very frequent RP finding.
  - target: Bone spicule pigmentation
    description: Chronic photoreceptor and retinal-pigment-epithelium injury produces characteristic pigment migration.
    evidence:
    - reference: ORPHA:791
      reference_title: Retinitis pigmentosa
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "HP:0007737 | Bone spicule pigmentation of the retina | Very frequent (99-80%)"
      explanation: Records bone-spicule retinal pigmentation as a very frequent RP finding.
  - target: Secondary cone and macular structural loss
    description: Continuing rod-cone degeneration extends to central retinal structure and function.
    evidence:
    - reference: PMID:42022048
      reference_title: Genetic and Phenotypic Characterization of a Large Cohort of Patients with BBS1-Retinopathy.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        The mean outer nuclear layer thickness (ONLT) at baseline and follow-up
        was 32.6 ± 21.5 μm and 25.6 ± 22.1 μm.
      explanation: Documents longitudinal loss of a photoreceptor-nuclear-layer structural measure.
- name: Secondary cone and macular structural loss
  description: >-
    Later cone involvement and macular thinning reduce central acuity.
    Photoreceptor outer-segment loss is visible on OCT, while cystoid macular
    edema can add a potentially treatable cause of central visual impairment.
  cell_types:
  - preferred_term: cone photoreceptor cell
    term:
      id: CL:0000573
      label: retinal cone cell
  locations:
  - preferred_term: retina
    term:
      id: UBERON:0000966
      label: retina
  evidence:
  - reference: PMID:42022048
    reference_title: Genetic and Phenotypic Characterization of a Large Cohort of Patients with BBS1-Retinopathy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The mean central macular thickness (CMT) at baseline and follow-up was
      179.7 ± 43.1 μm and 166.6 ± 50.3 μm.
    explanation: Shows longitudinal central macular thinning in BBS1 retinopathy.
  downstream:
  - target: Progressive visual loss
    description: Progressive central structural loss worsens vision over years.
    evidence:
    - reference: ORPHA:791
      reference_title: Retinitis pigmentosa
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        Retinitis pigmentosa (RP) is an inherited retinal dystrophy leading to
        progressive loss of the photoreceptors and retinal pigment epithelium
        and resulting in blindness usually after several decades.
      explanation: Establishes progressive visual loss as the broad RP trajectory.
  - target: Visual impairment
    description: Macular and cone involvement reduce central visual function.
    evidence:
    - reference: PMID:23143442
      reference_title: BBS1 mutations in a wide spectrum of phenotypes ranging from nonsyndromic retinitis pigmentosa to Bardet-Biedl syndrome.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "In 8 of 14 patients, visual acuity was significantly reduced."
      explanation: Documents reduced acuity in BBS1-associated retinal disease.
  - target: Photoreceptor outer segment loss on macular OCT
    description: Outer-retinal structural loss is visible on macular OCT.
    evidence:
    - reference: ORPHA:791
      reference_title: Retinitis pigmentosa
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "HP:0030610 | Photoreceptor outer segment loss on macular OCT | Frequent (79-30%)"
      explanation: Records this OCT finding as frequent in RP.
  - target: Cystoid macular edema
    description: Cystoid macular edema can superimpose additional central visual dysfunction.
    evidence:
    - reference: ORPHA:791
      reference_title: Retinitis pigmentosa
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "HP:0011505 | Cystoid macular edema | Frequent (79-30%)"
      explanation: Records cystoid macular edema as a frequent RP complication.
phenotypes:
- name: Rod-cone dystrophy
  category: Ocular
  diagnostic: true
  description: >-
    A rod-predominant inherited retinal dystrophy with later cone involvement is
    the defining manifestation of this class.
  phenotype_term:
    preferred_term: rod-cone dystrophy
    term:
      id: HP:0000510
      label: Rod-cone dystrophy
  evidence:
  - reference: PMID:23143442
    reference_title: BBS1 mutations in a wide spectrum of phenotypes ranging from nonsyndromic retinitis pigmentosa to Bardet-Biedl syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In patients with electroretinographic responses, a rod-cone pattern of
      photoreceptor degeneration was observed.
    explanation: Directly identifies the rod-cone pattern in BBS1-associated RP.
- name: Nyctalopia
  category: Ocular
  frequency: FREQUENT
  description: Night blindness is an early functional consequence of rod dysfunction.
  phenotype_term:
    preferred_term: Nyctalopia
    term:
      id: HP:0000662
      label: Nyctalopia
  evidence:
  - reference: ORPHA:791
    reference_title: Retinitis pigmentosa
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0000662 | Nyctalopia | Frequent (79-30%)"
    explanation: Provides broad RP frequency support.
- name: Peripheral visual field loss
  category: Ocular
  frequency: FREQUENT
  description: Rod-rich peripheral retinal degeneration produces progressive field constriction.
  phenotype_term:
    preferred_term: Peripheral visual field loss
    term:
      id: HP:0007994
      label: Peripheral visual field loss
  evidence:
  - reference: ORPHA:791
    reference_title: Retinitis pigmentosa
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0007994 | Peripheral visual field loss | Frequent (79-30%)"
    explanation: Provides broad RP frequency support.
- name: Abnormal electroretinogram
  category: Ocular
  frequency: VERY_FREQUENT
  description: Full-field ERG usually demonstrates rod-cone dysfunction and may become non-recordable.
  phenotype_term:
    preferred_term: Abnormal electroretinogram
    term:
      id: HP:0000512
      label: Abnormal electroretinogram
  evidence:
  - reference: ORPHA:791
    reference_title: Retinitis pigmentosa
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0000512 | Abnormal electroretinogram | Very frequent (99-80%)"
    explanation: Provides broad RP frequency support.
  - reference: PMID:42022048
    reference_title: Genetic and Phenotypic Characterization of a Large Cohort of Patients with BBS1-Retinopathy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Of the patients who had electrophysiology available, 19 of 27 had
      rod-cone pattern dysfunction
    explanation: Supplies BBS1-specific electrophysiologic data.
- name: Bone spicule pigmentation
  category: Ocular
  frequency: VERY_FREQUENT
  description: Mid-peripheral bone-spicule pigmentation is a characteristic later fundus sign.
  phenotype_term:
    preferred_term: Bone spicule pigmentation of the retina
    term:
      id: HP:0007737
      label: Spicular pigmentation of the retina
  evidence:
  - reference: ORPHA:791
    reference_title: Retinitis pigmentosa
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0007737 | Bone spicule pigmentation of the retina | Very frequent (99-80%)"
    explanation: Provides broad RP frequency support.
- name: Progressive visual loss
  category: Ocular
  description: Visual function declines over years to decades as retinal degeneration advances.
  phenotype_term:
    preferred_term: Progressive visual loss
    term:
      id: HP:0000529
      label: Progressive visual loss
  evidence:
  - reference: PMID:42022048
    reference_title: Genetic and Phenotypic Characterization of a Large Cohort of Patients with BBS1-Retinopathy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The median BCVA was 0.47 logarithm of minimum angle of resolution (LogMAR)
      (interquartile range 0.3-0.8) at baseline and 1.3 LogMAR (interquartile
      range 0.7-2.4) at follow-up, with an average decline of 0.05 LogMAR/year.
    explanation: Quantifies progressive acuity loss in BBS1 retinopathy.
- name: Visual impairment
  category: Ocular
  frequency: VERY_FREQUENT
  description: Central acuity becomes impaired with cone and macular involvement.
  phenotype_term:
    preferred_term: Visual impairment
    term:
      id: HP:0000505
      label: Visual impairment
  evidence:
  - reference: ORPHA:791
    reference_title: Retinitis pigmentosa
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0000505 | Visual impairment | Very frequent (99-80%)"
    explanation: Provides broad RP frequency support.
- name: Photoreceptor outer segment loss on macular OCT
  category: Ocular
  frequency: FREQUENT
  description: Macular OCT can show progressive loss of outer-segment structure and outer-nuclear-layer thinning.
  phenotype_term:
    preferred_term: Photoreceptor outer segment loss on macular OCT
    term:
      id: HP:0030610
      label: Photoreceptor outer segment loss on macular OCT
  evidence:
  - reference: ORPHA:791
    reference_title: Retinitis pigmentosa
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0030610 | Photoreceptor outer segment loss on macular OCT | Frequent (79-30%)"
    explanation: Provides broad RP frequency support.
- name: Cystoid macular edema
  category: Ocular
  frequency: FREQUENT
  description: Cystoid macular edema is a potentially treatable complication that can worsen central vision.
  phenotype_term:
    preferred_term: Cystoid macular edema
    term:
      id: HP:0011505
      label: Cystoid macular edema
  evidence:
  - reference: ORPHA:791
    reference_title: Retinitis pigmentosa
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0011505 | Cystoid macular edema | Frequent (79-30%)"
    explanation: Provides broad RP frequency support.
diagnosis:
- name: Ophthalmic and systemic phenotyping
  presence: Positive retinal findings with absent or limited systemic BBS features at ascertainment
  description: >-
    Document the rod-cone retinal phenotype and actively review obesity,
    polydactyly, renal disease, hypogonadism, hearing, neurodevelopment, and
    cognition. A patient initially labeled nonsyndromic may lie on a mild or
    age-dependent Bardet-Biedl spectrum.
  diagnosis_term:
    preferred_term: ophthalmologist evaluation
    term:
      id: NCIT:C38060
      label: Eye Examination
  evidence:
  - reference: PMID:37031301
    reference_title: Phenotypic diversity observed in a Chinese patient cohort with biallelic variants in Bardet-Biedl syndrome genes.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      All patients underwent ophthalmic and systematic evaluations, as well as
      comprehensive molecular genetic analyses.
    explanation: Supports combined ocular, systemic, and molecular assessment.
- name: Full-field electroretinography
  presence: Rod-cone dysfunction
  description: >-
    Full-field ERG establishes the physiologic rod-cone pattern, distinguishes
    cone-rod or macular-predominant presentations, and supports longitudinal
    functional staging.
  diagnosis_term:
    preferred_term: electroretinogram procedure
    term:
      id: NCIT:C101217
      label: Retinal Examination
  evidence:
  - reference: PMID:42022048
    reference_title: Genetic and Phenotypic Characterization of a Large Cohort of Patients with BBS1-Retinopathy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Of the patients who had electrophysiology available, 19 of 27 had
      rod-cone pattern dysfunction, (6/27) a similar degree of rod and cone
      dysfunction.
    explanation: Demonstrates the diagnostic electrophysiologic spectrum in BBS1 retinopathy.
- name: Optical coherence tomography
  presence: Outer-retinal and macular thinning, with or without cystoid edema
  description: >-
    OCT documents outer-segment and outer-nuclear-layer loss, measures central
    macular thickness, detects cystoid macular edema, and supplies longitudinal
    structural endpoints.
  diagnosis_term:
    preferred_term: optical coherence tomography
    term:
      id: NCIT:C20828
      label: Optical Coherence Tomography
  evidence:
  - reference: PMID:42022048
    reference_title: Genetic and Phenotypic Characterization of a Large Cohort of Patients with BBS1-Retinopathy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Retinal imaging and electrophysiology were analyzed cross-sectionally and
      longitudinally.
    explanation: Supports retinal imaging as a longitudinal assessment in molecularly confirmed BBS1 disease.
- name: Visual field testing
  presence: Peripheral field constriction
  description: >-
    Kinetic or static perimetry quantifies peripheral field loss and follows
    functional progression.
  diagnosis_term:
    preferred_term: vision assessment
    term:
      id: NCIT:C156778
      label: Vision Assessment
  evidence:
  - reference: ORPHA:791
    reference_title: Retinitis pigmentosa
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0007994 | Peripheral visual field loss | Frequent (79-30%)"
    explanation: Establishes the field deficit that perimetry measures.
- name: Molecular genetic testing with splice and noncoding coverage
  presence: Biallelic pathogenic or likely pathogenic variants in an included gene
  description: >-
    An inherited-retinal-disease panel, exome, or genome approach should assess
    ARL6, TTC8, BBS1, BBS2, BBS9, and other RP or ciliopathy genes. Analysis
    must not stop at coding exons: retina-specific exons, canonical and
    noncanonical splice sites, deep-intronic or branchpoint regions, and
    appropriate copy-number analysis may be needed. Molecular results should be
    interpreted alongside deliberate systemic re-phenotyping.
  diagnosis_term:
    preferred_term: genetic testing
    term:
      id: NCIT:C15709
      label: Genetic Testing
  evidence:
  - reference: PMID:33910932
    reference_title: BBS1 branchpoint variant is associated with non-syndromic retinitis pigmentosa.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      this research highlights the importance of the analysis of non-coding
      regions in order to provide a conclusive molecular diagnosis.
    explanation: Directly supports noncoding-region analysis in unresolved BBS1-associated RP.
  - reference: PMID:20451172
    reference_title: A splice-site mutation in a retina-specific exon of BBS8 causes nonsyndromic retinitis pigmentosa.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      subsequent systematic sequencing of candidate transcripts identified a
      homozygous splice-site mutation in a previously unknown BBS8 exon.
    explanation: Shows why retina-specific exon coverage matters for TTC8-RP51.
  - reference: PMID:20301590
    reference_title: Nonsyndromic Retinitis Pigmentosa Overview.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Provide an evaluation strategy to identify the genetic cause of
      nonsyndromic retinitis pigmentosa in a proband
    explanation: Supports a genetics-directed diagnostic evaluation for nonsyndromic RP.
differential_diagnoses:
- name: Bardet-Biedl syndrome
  description: >-
    Full or mild BBS shares the same genes and retinal mechanism. Obesity,
    polydactyly, renal or genitourinary disease, neurodevelopmental findings, and
    other extra-ocular features favor syndromic classification; absence at one
    visit may reflect age or mild expressivity.
  distinguishing_features:
  - Multisystem involvement rather than retina-dominant disease
  - Systemic surveillance may reveal age-dependent features
  evidence:
  - reference: PMID:37031301
    reference_title: Phenotypic diversity observed in a Chinese patient cohort with biallelic variants in Bardet-Biedl syndrome genes.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The patients exhibited clinical heterogeneity, from patients with all six
      primary clinical components to patients suffering from non-syndromic RP.
    explanation: Directly establishes the syndromic-to-isolated spectrum.
- name: Nonsyndromic retinitis pigmentosa from non-BBSome genes
  description: >-
    Many phototransduction, outer-segment, retinoid-cycle, splicing, and other
    ciliary genes can produce an indistinguishable rod-cone dystrophy. Molecular
    diagnosis, rather than retinal appearance alone, identifies this BBSome
    class.
  distinguishing_features:
  - Pathogenic variants in another RP gene
  - No BBSome-gene allelic explanation
  evidence:
  - reference: PMID:33910932
    reference_title: BBS1 branchpoint variant is associated with non-syndromic retinitis pigmentosa.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Inherited retinal diseases (IRDs) can be caused by variants in >270 genes."
    explanation: Establishes the extensive genetic differential for inherited retinal disease.
- name: Other syndromic retinal ciliopathies
  description: >-
    Alström, Senior-Løken, Joubert, and other ciliary disorders may combine
    retinal degeneration with renal, neurologic, metabolic, hearing, or skeletal
    findings. Broader phenotype and non-BBSome molecular results distinguish
    them.
  distinguishing_features:
  - Syndrome-specific extra-ocular findings
  - Causal variants outside the five-gene BBSome-RP scope
  evidence:
  - reference: PMID:37293546
    reference_title: Comparative analysis of transcriptional changes in zebrafish cep290 and bbs2 mutants by RNA-seq reveals upregulation of inflammatory and stress-related pathways.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      The mutations in ciliopathy genes disrupt distinct components of the
      cilium, yet all cause retinal degeneration.
    explanation: Supports mechanistically distinct ciliopathies as retinal-degeneration differentials.
treatments:
- name: Low-vision rehabilitation and adaptive support
  description: >-
    Magnification, contrast and lighting optimization, orientation and mobility
    training, educational or workplace accommodations, and assistive technology
    are individualized as acuity and field loss progress.
  treatment_term:
    preferred_term: supportive care
    term:
      id: NCIT:C15747
      label: Supportive Care
  target_phenotypes:
  - preferred_term: Progressive visual loss
    term:
      id: HP:0000529
      label: Progressive visual loss
  - preferred_term: Peripheral visual field loss
    term:
      id: HP:0007994
      label: Peripheral visual field loss
  evidence:
  - reference: ORPHA:791
    reference_title: Retinitis pigmentosa
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Retinitis pigmentosa (RP) is an inherited retinal dystrophy leading to
      progressive loss of the photoreceptors and retinal pigment epithelium and
      resulting in blindness usually after several decades.
    explanation: The progressive functional burden supports continuing rehabilitative care.
- name: Ophthalmic surveillance and complication management
  description: >-
    Serial acuity, visual-field, OCT, and examination assessments document
    progression and detect potentially treatable contributors such as cystoid
    macular edema or cataract. Management should be individualized by a retinal
    specialist; surveillance is not a disease-modifying treatment.
  treatment_term:
    preferred_term: eye examination
    term:
      id: NCIT:C38060
      label: Eye Examination
  target_phenotypes:
  - preferred_term: Cystoid macular edema
    term:
      id: HP:0011505
      label: Cystoid macular edema
  - preferred_term: Progressive visual loss
    term:
      id: HP:0000529
      label: Progressive visual loss
  evidence:
  - reference: PMID:42022048
    reference_title: Genetic and Phenotypic Characterization of a Large Cohort of Patients with BBS1-Retinopathy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Retinal imaging and electrophysiology were analyzed cross-sectionally and
      longitudinally.
    explanation: Supports longitudinal multimodal retinal assessment.
  - reference: ORPHA:791
    reference_title: Retinitis pigmentosa
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0011505 | Cystoid macular edema | Frequent (79-30%)"
    explanation: Establishes a common retinal complication that surveillance can detect.
- name: Genetic counseling
  description: >-
    Counseling addresses autosomal recessive recurrence, carrier testing,
    reproductive options, the gene-specific allelic spectrum, and uncertainty
    about later systemic BBS manifestations. Molecularly confirmed relatives
    should receive phenotype-appropriate evaluation.
  treatment_term:
    preferred_term: genetic counseling
    term:
      id: NCIT:C15240
      label: Genetic Counseling
  evidence:
  - reference: PMID:37031301
    reference_title: Phenotypic diversity observed in a Chinese patient cohort with biallelic variants in Bardet-Biedl syndrome genes.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Genetic analysis is therefore crucial for diagnosis, genetic counseling,
      and future gene therapy in these patients.
    explanation: Directly supports genetic counseling in BBS-gene retinal disease.
clinical_trials:
- name: NCT07269665
  phase: PHASE_I
  status: NOT_RECRUITING
  description: >-
    First-in-human, open-label, dose-escalation study of a single intraocular
    AXV-101 dose in participants aged 4-17 years with biallelic BBS1 variants
    and retinal degeneration. The study evaluates preliminary safety,
    tolerability, dose, pharmacodynamics, ocular structural and functional
    change, and systemic pharmacokinetics; it does not establish efficacy.
  target_phenotypes:
  - preferred_term: Rod-cone dystrophy
    term:
      id: HP:0000510
      label: Rod-cone dystrophy
  - preferred_term: Progressive visual loss
    term:
      id: HP:0000529
      label: Progressive visual loss
  evidence:
  - reference: clinicaltrials:NCT07269665
    reference_title: A First-In-Human, Open Label, Dose Escalation Trial to Evaluate the Safety, Tolerability and Pharmacodynamics of a Single Dose of AXV-101 in Patients With Bardet-Biedl Syndrome 1 (BBS1) Bi-Allelic Mutations and Retinal Degeneration
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The goal of this first in human study is to evaluate the preliminary
      safety and tolerability of AXV-101 in participants with BBS1.
    explanation: Identifies the first-in-human BBS1 retinal gene-therapy safety study.
  notes: >-
    ClinicalTrials.gov listed the study as NOT_YET_RECRUITING on 2026-07-23;
    represented as NOT_RECRUITING because that is the closest available schema
    status. ClinicalTrials.gov describes it as Early Phase 1; represented as
    PHASE_I because the schema has no Early Phase 1 value.
animal_models:
- species: Danio rerio
  genotype: bbs3 knockdown with BBS3 or BBS3L p.Ala89Val rescue constructs
  description: >-
    Zebrafish rescue assays separate a preserved general transport function from
    failure to rescue visual impairment by BBS3L p.Ala89Val, modeling the
    retina-selective ARL6 allele effect.
  associated_phenotypes:
  - Visual impairment
  - Intracellular transport delay
  evidence:
  - reference: PMID:21282186
    reference_title: Functional analysis of BBS3 A89V that results in non-syndromic retinal degeneration.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      BBS3L A89V, however, was unable to rescue vision impairment, highlighting
      a role for a specific amino acid within BBS3 that is necessary for visual
      function, but dispensable in other cell types.
    explanation: Demonstrates a retina-selective functional deficit in vivo.
- species: Danio rerio
  genotype: bbs1 null mutant
  description: >-
    Bbs1 loss destabilizes the BBSome in outer segments, changes protein and
    lipid composition, produces early functional deficits, and later causes
    outer-segment disorganization and retinal degeneration.
  associated_phenotypes:
  - Early visual dysfunction
  - Outer-segment protein accumulation
  - Increased outer-segment cholesterol
  - Progressive retinal degeneration
  evidence:
  - reference: PMID:35277505
    reference_title: Loss of the Bardet-Biedl protein Bbs1 alters photoreceptor outer segment protein and lipid composition.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Using a bbs1 zebrafish mutant, we show that retinal development and
      photoreceptor differentiation are unaffected by Bbs1-loss, supported by
      an initially unaffected transcriptome.
    explanation: Identifies the Bbs1-null zebrafish model and its initially preserved retinal development.
- species: Mus musculus
  genotype: Bbs1 p.Met390Arg homozygous knock-in
  description: >-
    The recurrent human BBS1 allele produces retinal degeneration in mice.
    TUDCA preserved ERG and outer-nuclear-layer measures in this model, but the
    experiment is preclinical and does not establish a human treatment.
  associated_phenotypes:
  - Reduced electroretinogram response
  - Outer nuclear layer loss
  - Retinal thinning
  evidence:
  - reference: PMID:22110077
    reference_title: TUDCA slows retinal degeneration in two different mouse models of retinitis pigmentosa and prevents obesity in Bardet-Biedl syndrome type 1 mice.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      TUDCA treatment preserved ERG b-waves and the outer nuclear layer in
      Bbs1(M390R/M390R) mice, and prevented obesity assessed at P120.
    explanation: Demonstrates structural and functional rescue in a BBS1 allele-specific mouse model.
- species: Mus musculus
  genotype: Bbs8 knockout
  description: >-
    Bbs8 loss alters retinal-pigment-epithelium transcript and protein
    expression before and during retinal degeneration, broadening the cellular
    context beyond photoreceptors.
  associated_phenotypes:
  - Retinal pigment epithelium gene-expression dysregulation
  - Retinal degeneration
  evidence:
  - reference: PMID:33681195
    reference_title: Loss of Ciliary Gene Bbs8 Results in Physiological Defects in the Retinal Pigment Epithelium.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      We demonstrate that upon loss of Bbs8, predominantly thought to be a
      ciliary gene, the RPE shows changes in gene and protein expression
      initially involved in signaling pathways and developmental processes
    explanation: Establishes molecular RPE changes after Bbs8 loss.
- species: Danio rerio
  genotype: bbs2 homozygous mutant
  description: >-
    Adult mutant retinas undergo progressive cone loss with inflammatory and
    stress-response activation and fail to mount an effective regenerative
    response.
  associated_phenotypes:
  - Progressive cone photoreceptor loss
  - Microglial activation
  - Retinal inflammatory signaling
  evidence:
  - reference: PMID:37293546
    reference_title: Comparative analysis of transcriptional changes in zebrafish cep290 and bbs2 mutants by RNA-seq reveals upregulation of inflammatory and stress-related pathways.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      zebrafish carrying mutations in cep290 or bbs2 undergo progressive loss
      of cone photoreceptors and exhibit signs of microglia activation and
      inflammation, but the mutants fail to stimulate a regeneration response.
    explanation: Defines the degenerative and inflammatory bbs2-mutant retinal phenotype.
experimental_models:
- name: KCi001-A BBS1 patient-derived induced pluripotent stem cell line
  experimental_model_type: CELL_LINE
  organism:
    preferred_term: human
    term:
      id: NCBITaxon:9606
      label: Homo sapiens
  cell_source: Peripheral-cell-derived iPSC from a patient with compound-heterozygous BBS1 variants
  description: >-
    A patient-derived pluripotent resource carrying BBS1 p.Met390Arg and
    p.Gly370Arg. The donor had Bardet-Biedl syndrome rather than confirmed
    isolated RP, and the undifferentiated line is a platform for downstream
    retinal differentiation rather than a validated retinal phenotype model.
  conditions:
  - BBS1 c.1169T>G and c.1135G>C compound heterozygosity
  publication: PMID:30142598
  evidence:
  - reference: PMID:30142598
    reference_title: "Generation of induced pluripotent stem cells, KCi001-A derived from a Bardet-Biedl syndrome patient compound heterozygous for the BBS1 variants c.1169T>G/c.1135G>C."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Here we describe the successful generation of an induced pluripotent stem
      cell (iPSC) KCi001-A from a BBS patient compound heterozygous for two
      disease causing BBS1 variants
    explanation: Establishes the genotype-defined human iPSC resource.
- name: IBMS-iPSC-063-06 BBS2 patient-derived induced pluripotent stem cell line
  experimental_model_type: CELL_LINE
  organism:
    preferred_term: human
    term:
      id: NCBITaxon:9606
      label: Homo sapiens
  cell_source: Patient-derived iPSC carrying a homozygous BBS2 splice variant
  description: >-
    A pluripotent human resource retaining the BBS2 c.534+1G>T variant. The
    donor had syndromic BBS, so this resource models BBS2 loss in a human
    background but is not evidence for isolated RP.
  conditions:
  - Homozygous BBS2 c.534+1G>T
  publication: PMID:34364070
  evidence:
  - reference: PMID:34364070
    reference_title: "Generation of induced pluripotent stem cells from a Bardet-Biedl syndrome patient carrying a homologous BBS2 c.534 + 1G > T mutation."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      We reported the generation and characterization of an iPS cell line,
      IBMS-iPSC-063-06, from a patient carrying the BBS2 homologous c534 + 1G > T
      mutation.
    explanation: Establishes the genotype-defined human BBS2 iPSC resource.
datasets:
- accession: geo:GSE144847
  title: Bbs8-deficient mouse retinal pigment epithelium transcriptomics
  description: >-
    GEO SuperSeries containing P11 and P29 Bbs8-knockout versus wild-type mouse
    RPE expression studies (subseries GSE144845 and GSE144846), associated with
    the published RPE transcriptomic and proteomic analysis.
  organism:
    preferred_term: mouse
    term:
      id: NCBITaxon:10090
      label: Mus musculus
  data_type: BULK_RNA_SEQ
  conditions:
  - Bbs8 knockout retinal pigment epithelium
  - Wild-type retinal pigment epithelium
  genes:
  - preferred_term: Bbs8
    term:
      id: MGI:1924290
      label: Bbs8
  publication: PMID:33681195
  evidence:
  - reference: PMID:33681195
    reference_title: Loss of Ciliary Gene Bbs8 Results in Physiological Defects in the Retinal Pigment Epithelium.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      We demonstrate that upon loss of Bbs8, predominantly thought to be a
      ciliary gene, the RPE shows changes in gene and protein expression
      initially involved in signaling pathways and developmental processes
    explanation: Describes molecular profiling of Bbs8-deficient retinal pigment epithelium.
- accession: geo:GSE223277
  title: bbs2-mutant zebrafish retina RNA sequencing
  description: >-
    Bulk retinal RNA-seq comparing adult bbs2-mutant, cep290-mutant, and
    wild-type zebrafish during photoreceptor degeneration.
  organism:
    preferred_term: zebrafish
    term:
      id: NCBITaxon:7955
      label: Danio rerio
  data_type: BULK_RNA_SEQ
  conditions:
  - bbs2 homozygous mutant retina
  - cep290 homozygous mutant retina
  - Wild-type retina
  publication: PMID:37293546
  evidence:
  - reference: PMID:37293546
    reference_title: Comparative analysis of transcriptional changes in zebrafish cep290 and bbs2 mutants by RNA-seq reveals upregulation of inflammatory and stress-related pathways.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      RNA-seq transcriptional profiling was performed on cep290-/- and bbs2-/-
      retinas.
    explanation: Directly identifies the mutant-retina bulk RNA-seq experiment.
discussions:
- discussion_id: bbsome_rp_lump_split_boundary
  prompt: >-
    When should a retina-dominant BBS-gene presentation remain in an
    isolated-RP class rather than be classified as mild Bardet-Biedl syndrome?
  kind: INTERPRETATION
  status: OPEN
  attaches_to:
  - definitions#BBSome-related isolated-RP scope
  - differential_diagnoses#Bardet-Biedl syndrome
  rationale: >-
    Published cohorts span apparently nonsyndromic RP, very mild extra-ocular
    disease, and full BBS. Age at assessment and the intensity of systemic
    phenotyping can change the label. This entry therefore uses a
    mechanism-based lump while retaining the clinical boundary as uncertain.
  evidence:
  - reference: PMID:37031301
    reference_title: Phenotypic diversity observed in a Chinese patient cohort with biallelic variants in Bardet-Biedl syndrome genes.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The patients exhibited clinical heterogeneity, from patients with all six
      primary clinical components to patients suffering from non-syndromic RP.
    explanation: Demonstrates the continuum that makes the classification boundary unstable.
- discussion_id: hypomorphic_allele_model_limits
  prompt: >-
    How consistently does residual BBSome function predict retina-restricted
    disease across genes and allelic combinations?
  kind: KNOWLEDGE_GAP
  status: OPEN
  attaches_to:
  - pathophysiology#Partial or retina-selective BBSome dysfunction
  rationale: >-
    Tissue-specific TTC8 and ARL6 effects and partial BBS9 splicing support a
    residual-function model, but BBS1 expressivity also implicates cis- or
    trans-acting modifiers. The model should not be generalized to every
    missense allele without functional and longitudinal clinical data.
  evidence:
  - reference: PMID:23143442
    reference_title: BBS1 mutations in a wide spectrum of phenotypes ranging from nonsyndromic retinitis pigmentosa to Bardet-Biedl syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      cis - or trans -acting modifiers may influence the disease phenotype.
    explanation: Directly identifies modifier effects as an alternative to a simple allele-severity rule.
- discussion_id: bbsome_rp_translation
  prompt: >-
    Will preclinical neuroprotection or BBS1 gene augmentation preserve useful
    vision in humans with BBSome-related retinal degeneration?
  kind: KNOWLEDGE_GAP
  status: OPEN
  attaches_to:
  - clinical_trials#NCT07269665
  - animal_models#Bbs1 p.Met390Arg homozygous knock-in
  rationale: >-
    TUDCA rescue is limited to mouse experiments, and AXV-101 is an early
    first-in-human safety and dose study. Neither establishes clinical efficacy,
    and evidence from BBS1 cannot yet be transferred to all five genes.
  evidence:
  - reference: PMID:22110077
    reference_title: TUDCA slows retinal degeneration in two different mouse models of retinitis pigmentosa and prevents obesity in Bardet-Biedl syndrome type 1 mice.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      The Rd1 and rd16 mice showed no improvement with TUDCA treatment
    explanation: Shows model-dependent response and cautions against class-wide translation.
  - reference: clinicaltrials:NCT07269665
    reference_title: A First-In-Human, Open Label, Dose Escalation Trial to Evaluate the Safety, Tolerability and Pharmacodynamics of a Single Dose of AXV-101 in Patients With Bardet-Biedl Syndrome 1 (BBS1) Bi-Allelic Mutations and Retinal Degeneration
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Is AXV-101 safe and tolerable to use in participants with BBS1?
    explanation: Confirms that the current human study is framed around safety and tolerability.
references:
- reference: ORPHA:791
  title: Retinitis pigmentosa
  findings: []
- reference: PMID:20301590
  title: Nonsyndromic Retinitis Pigmentosa Overview.
  tags:
  - GeneReviews
  findings: []
- reference: PMID:20451172
  title: A splice-site mutation in a retina-specific exon of BBS8 causes nonsyndromic retinitis pigmentosa.
  findings: []
- reference: PMID:21282186
  title: Functional analysis of BBS3 A89V that results in non-syndromic retinal degeneration.
  findings: []
- reference: PMID:22110077
  title: TUDCA slows retinal degeneration in two different mouse models of retinitis pigmentosa and prevents obesity in Bardet-Biedl syndrome type 1 mice.
  findings: []
- reference: PMID:22353939
  title: In search of triallelism in Bardet-Biedl syndrome.
  findings: []
- reference: PMID:23143442
  title: BBS1 mutations in a wide spectrum of phenotypes ranging from nonsyndromic retinitis pigmentosa to Bardet-Biedl syndrome.
  findings: []
- reference: PMID:25541840
  title: Association between missense mutations in the BBS2 gene and nonsyndromic retinitis pigmentosa.
  findings: []
- reference: PMID:26195043
  title: Confirmation of TTC8 as a disease gene for nonsyndromic autosomal recessive retinitis pigmentosa (RP51).
  findings: []
- reference: PMID:30142598
  title: "Generation of induced pluripotent stem cells, KCi001-A derived from a Bardet-Biedl syndrome patient compound heterozygous for the BBS1 variants c.1169T>G/c.1135G>C."
  findings: []
- reference: PMID:33681195
  title: Loss of Ciliary Gene Bbs8 Results in Physiological Defects in the Retinal Pigment Epithelium.
  findings: []
- reference: PMID:33910932
  title: BBS1 branchpoint variant is associated with non-syndromic retinitis pigmentosa.
  findings: []
- reference: PMID:34364070
  title: "Generation of induced pluripotent stem cells from a Bardet-Biedl syndrome patient carrying a homologous BBS2 c.534 + 1G > T mutation."
  findings: []
- reference: PMID:35277505
  title: Loss of the Bardet-Biedl protein Bbs1 alters photoreceptor outer segment protein and lipid composition.
  findings: []
- reference: PMID:37031301
  title: Phenotypic diversity observed in a Chinese patient cohort with biallelic variants in Bardet-Biedl syndrome genes.
  findings: []
- reference: PMID:37293546
  title: Comparative analysis of transcriptional changes in zebrafish cep290 and bbs2 mutants by RNA-seq reveals upregulation of inflammatory and stress-related pathways.
  findings: []
- reference: PMID:38534779
  title: Autosomal Recessive Rod-Cone Dystrophy with Mild Extra-Ocular Manifestations Due to a Splice-Affecting Variant in BBS9.
  findings: []
- reference: PMID:42022048
  title: Genetic and Phenotypic Characterization of a Large Cohort of Patients with BBS1-Retinopathy.
  findings: []
- reference: clinicaltrials:NCT07269665
  title: A First-In-Human, Open Label, Dose Escalation Trial to Evaluate the Safety, Tolerability and Pharmacodynamics of a Single Dose of AXV-101 in Patients With Bardet-Biedl Syndrome 1 (BBS1) Bi-Allelic Mutations and Retinal Degeneration
  findings: []
review_notes: >-
  Comprehensive re-review completed 2026-07-23. The entry retains a strict
  five-gene BBSome scope; corrects the BBS9 citation title; separates broader
  ClinGen ciliopathy assertions from isolated-RP evidence; adds gene-to-mechanism
  wiring, evidence on every causal edge, natural history, expanded phenotypes,
  diagnostic and differential guidance, supportive management, a current BBS1
  trial, animal and human cellular models, GEO datasets, and explicit
  interpretation gaps. No exact-class population prevalence is asserted because
  available percentages describe broad RP or gene-specific referral cohorts,
  not this five-gene mechanistic class.

📚

References & Deep Research